This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in


Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This multicentre, randomised, double-blind, placebo controlled trial enrolled 1749 patients with:

  • acute MI
  • wall motion index of 1.2 or below i.e. with significant left ventricular dysfunction and a high risk of death

Trandolapril therapy was commenced 3-7 days after MI and continued indefinitely.

Mortality was 22% lower in the Trandolapril arms when compared to the placebo arm.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page